ArticleJournal of pharmaceutical analysis2025

Emodin is a novel phosphatidylethanolamine anabolism inhibitor that reprograms lipid metabolism to overcome 5-fluorouracil resistance in colorectal cancer.

Yanyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.